Literature DB >> 6744158

[Laparotomy in Hodgkin's disease: significance of splenic involvement].

E Tawil, J P Mercier.   

Abstract

We retrospectively reviewed 224 cases of Hodgkin's disease, in 120 of which staging laparotomy was performed. The surgical findings in cases of clinical stage I or II disease with supradiaphragmatic presentation or clinical stage III disease did not influence the treatment plans. Of the 64 patients with positive results of laparotomy (splenic or lymph node involvement or both) 51 had splenic involvement; their 5-year survival rate, 57%, was similar to that of the patients with clinical or pathological stage III disease - 58% and 54% respectively. At laparotomy 11 patients with pathological stage III disease were found to have isolated splenic involvement; their 5-year survival rate, 64%, was not appreciably different from that of the patients with clinical stage II disease, 70%; both groups were treated with radiotherapy only. From this study we can conclude that splenic involvement in Hodgkin's disease has no deleterious effect on survival and that splenic irradiation seems to be as effective as splenectomy in controlling the disease.

Entities:  

Mesh:

Year:  1984        PMID: 6744158      PMCID: PMC1483241     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease.

Authors:  M Tubiana; M Henry-Amar; M Hayat; K Breur; B van der Werf-Messing; M Burgers
Journal:  Eur J Cancer       Date:  1979-05       Impact factor: 9.162

Review 2.  Hodgkin's disease: problems of staging.

Authors:  D L Sweet; A Kinnealey; J E Ultmann
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

3.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

4.  The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.

Authors:  J A Levi; P H Wiernik
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

5.  Anatomical substages of stage III Hodgkin's disease: implications for staging, therapy, and experimental design.

Authors:  R S Stein; R M Hilborn; J M Flexner; M Bolin; S Stroup; V Reynolds; S Krantz
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

Review 6.  Hodgkin's disease: unfolding concepts concerning its nature, management and prognosis.

Authors:  H S Kaplan
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

7.  Prognostic factors in pathological stage IIIA Hodgkin's disease.

Authors:  R T Hoppe; S A Rosenberg; H S Kaplan; R S Cox
Journal:  Cancer       Date:  1980-09-01       Impact factor: 6.860

8.  Evaluation of diagnostic laparotomy and splenectomy in Hodgkin's disease (Report no 12).

Authors:  T S Worthy
Journal:  Clin Radiol       Date:  1981-09       Impact factor: 2.350

9.  [Post-radiation nephritis. Study of the renal consequences of splenic irradiation for lymphoma].

Authors:  J P Le Bourgeois; D Godefroy; M Di PAolo; C Parmentier; M Tubiana
Journal:  J Radiol Electrol Med Nucl       Date:  1975-11

10.  Second malignant neoplasms in patients treated for Hodgkin's disease with radiotherapy or radiotherapy and chemotherapy.

Authors:  D F Nelson; S Cooper; M G Weston; P Rubin
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.